Candel Therapeutics
CADL
CADL
20 hedge funds and large institutions have $4.86M invested in Candel Therapeutics in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.39% less ownership
Funds ownership: 18.57% → 18.18% (-0.39%)
28% less capital invested
Capital invested by funds: $6.77M → $4.86M (-$1.91M)
Holders
20
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$29.9K | |
| 2 | +$7.49K | |
| 3 | +$354 | |
| 4 |
JPMorgan Chase & Co
New York
|
+$16 |
| 5 |
Wells Fargo
San Francisco,
California
|
+$4 |
Top Sellers
| 1 | -$149K | |
| 2 | -$16K | |
| 3 | -$12.6K | |
| 4 |
BWM
Baystate Wealth Management
Boston,
Massachusetts
|
-$2.97K |
| 5 |
BlackRock
New York
|
-$1.82K |